APGE Stock-Based Compensation
Apogee Therapeutics Inc · Stock-Based Compensation
APGE Stock-Based Compensation
Latest reported$16.66Mperiod ending
APGE Quarterly Stock-Based Comp ($0.00 → $16.66M)
Quarterly stock-based compensation
High-resolution chart · PNG
APGE stock-based compensation history
Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | Stock-Based Compensation (USD) |
|---|---|
| 16,663,000 | |
| 17,155,000 | |
| 11,930,000 | |
| 11,877,000 | |
| 11,344,000 | |
| 11,126,000 | |
| 7,609,000 | |
| 5,839,000 | |
| 5,698,000 | |
| 4,186,000 | |
| 2,211,000 | |
| 1,505,000 | |
| 1,113,000 | |
| 1,274,000 | |
| 2,142,000 | |
| 0 | |
| 0 | |
| 0 |